A distinct mode of inhibition of Wnt signaling by dioscin was reported in an osteoarthritis mouse model, where mRNA expression of Wnt3a and β-catenin, sharply increased upon induction of the disease by iodoacetate, were counteracted by the compound treatment. The gene discussed is WNT3A; the disease is osteoarthritis.